Braemar Hotels & Resorts’ management said it has begun a company sale process, with Robert W. Baird & Co. as financial advisor, while also evaluating potential individual asset sales with broker co-advisors and noting there is no set timetable or assurance of a transaction. The company reported fourth-quarter 2025 comparable RevPAR was flat but comparable total revenue rose 1.8%, with resorts posting 4.1% RevPAR growth and 6.0% comparable hotel EBITDA growth; results were pressured by renovations at Cameo Beverly Hills, Hotel Yountville and Park Hyatt Beaver Creek. Braemar also highlighted the sale of The Clancy in San Francisco for $115 million, the rebranding of Cameo Beverly Hills to Hilton’s LXR brand, and approximately $149 million of non-traded preferred stock redemptions to date, while pointing to $78 million of 2025 capital spending and a 2026 capex outlook of $25 million to $35 million. The company noted financial details including $147.0 million of full-year adjusted EBITDAre and said its board has not set a 2026 common dividend policy amid the ongoing sale process; additional materials are available at www.sec.gov and www.bhrreit.com.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Braemar Hotel & Resorts Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001574085-26-000025), on February 27, 2026, and is solely responsible for the information contained therein.